Science
FDA Grants Orphan Status to Drug for Newborn Brain Injury
The FDA has granted orphan drug designation to Neuren Pharmaceuticals' NNZ-2591 for neonatal hypoxic-ischemic encephalopathy, a brain injury caused by…
The FDA has granted orphan drug designation to Neuren Pharmaceuticals' NNZ-2591 for neonatal hypoxic-ischemic encephalopathy, a brain injury caused by…